Compare FOLD & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | LRN |
|---|---|---|
| Founded | 2002 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.6B |
| IPO Year | 2007 | 2007 |
| Metric | FOLD | LRN |
|---|---|---|
| Price | $14.30 | $87.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $26.11 | ★ $106.75 |
| AVG Volume (30 Days) | ★ 7.8M | 1.7M |
| Earning Date | 02-18-2026 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.29 |
| EPS | N/A | ★ 6.50 |
| Revenue | $598,704,000.00 | ★ $2,519,167,000.00 |
| Revenue This Year | $21.49 | $5.47 |
| Revenue Next Year | $18.46 | $4.81 |
| P/E Ratio | ★ N/A | $13.30 |
| Revenue Growth | ★ 21.28 | 14.86 |
| 52 Week Low | $5.51 | $60.62 |
| 52 Week High | $14.38 | $171.17 |
| Indicator | FOLD | LRN |
|---|---|---|
| Relative Strength Index (RSI) | 79.26 | 81.02 |
| Support Level | $14.30 | $82.92 |
| Resistance Level | $14.31 | $89.17 |
| Average True Range (ATR) | 0.03 | 3.59 |
| MACD | -0.13 | 1.38 |
| Stochastic Oscillator | 35.00 | 83.01 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.